ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ ASX Shares
Invest like Warren Buffett and buy and hold these ASX shares
⏸️ ASX Shares
5 ASX shares I will never sell
⏸️ ASX Shares
New to investing? ASX growth shares to buy now
Share Fallers
Why Appen, Kogan, OZ Minerals, & ResMed shares are dropping lower
⏸️ Best ASX Shares
4 ASX shares I'm looking to buy today
⏸️ ASX Shares
2 of the best ASX healthcare shares to buy today
⏸️ ASX Shares
Where to invest $5,000 into ASX shares right now
⏸️ ASX Shares
3 ASX 200 shares to buy for strong returns
Share Market News
UBS picks the best and worst ASX stocks from the reporting season
Growth Shares
4 fantastic ASX growth shares to buy in September
Growth Shares
Buy and hold these fantastic ASX healthcare shares until at least 2030
⏸️ ASX Shares
Where to invest $100,000 into ASX shares right now
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
